has sponsored live events, journal education, and internet-based CME activities and has awarded more than 80,000 hours of CME credit.Online First from The Oncologist
- Hanging Up the Gloves
- Risk Assessment and Monitoring of Patients with Cancer Receiving Opioid Therapy
- A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient‐Centeredness, and Practice Context
- Safe Opioid Use, Storage, and Disposal Strategies in Cancer Pain Management
- Patient‐Friendly Language to Facilitate Treatment Choice for Patients with Cancer
Clinical Trials Results from The Oncologist
- Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial [CLINICAL TRIAL RESULTS]
- S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial [CLINICAL TRIAL RESULTS]
- A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance) [CLINICAL TRIAL RESULTS]
- Endostatin and Oxaliplatin-Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study [CLINICAL TRIAL RESULTS]
- A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer [CLINICAL TRIAL RESULTS]